Sensei Biotherapeutics, Inc.盘中异动早盘股价大跌5.03%

市场透视08-06

北京时间2025年08月06日22时30分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现异动，股价急速下跌5.03%。截至发稿，该股报7.83美元/股，成交量2248股，换手率0.18%，振幅4.13%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.86百万美元，每股收益-5.45美元，毛利-30000.00美元，市盈率-0.34倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2557614303?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-06 22:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2557614303","market":"us","top_or_hot":-1,"title":"Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌5.03%","media":"市场透视","content":"<div>\n<p>北京时间2025年08月06日22时30分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现异动，股价急速下跌5.03%。截至发稿，该股报7.83美元/股，成交量2248股，换手率0.18%，振幅4.13%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.86百万美元，每股收益-5.45美元，毛利-30000.00美元，市盈率-0.34倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062230359737a0cc&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌5.03%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSensei Biotherapeutics, Inc.盘中异动 早盘股价大跌5.03%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-06 22:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062230359737a0cc&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年08月06日22时30分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现异动，股价急速下跌5.03%。截至发稿，该股报7.83美元/股，成交量2248股，换手率0.18%，振幅4.13%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.86百万美元，每股收益-5.45美元，毛利-30000.00美元，市盈率-0.34倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062230359737a0cc&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062230359737a0cc&s=b","article_id":"2557614303","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062230359737a0cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2557614303","pubTimestamp":1754490635,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年08月06日22时30分，Sensei Biotherapeutics, Inc.股票出现异动，股价急速下跌5.03%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Bioxcel Therapeutics, Inc.、诺瓦瓦克斯医药、Biomx Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为555.17%、345.20%、43.17%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为45.15%、44.74%、36.81%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc是一家专注于为癌症患者发现和开发下一代疗法的免疫肿瘤学公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","SNSE":"Sensei Biotherapeutics, Inc."},"translate_title":"Sensei Biotherapeutics, Inc. shares tumbled 5.03% in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNSE":1},"content_text":"北京时间2025年08月06日22时30分，Sensei Biotherapeutics, Inc.（SNSE.us）股票出现异动，股价急速下跌5.03%。截至发稿，该股报7.83美元/股，成交量2248股，换手率0.18%，振幅4.13%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.86百万美元，每股收益-5.45美元，毛利-30000.00美元，市盈率-0.34倍。机构评级方面，在所有2家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Bioxcel Therapeutics, Inc.、诺瓦瓦克斯医药、Biomx Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为555.17%、345.20%、43.17%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 (To Pur Com)、Cingulate Inc C/Wts 10/12/2026 (To Pur Com)，振幅分别为45.15%、44.74%、36.81%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc是一家专注于为癌症患者发现和开发下一代疗法的免疫肿瘤学公司。其TMAb（肿瘤微环境激活生物制剂）平台正在开发选择性疗法，旨在在肿瘤微环境中选择性地禁用免疫抑制信号或激活免疫刺激信号。该公司有四个在不同开发阶段的研究产品候选者：SNS-101（VISTA）、SNS-102（VSIG4）、SNS-103（ENTPDase/CD39）、SNS-201（VISTAxCD28）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2557614303","isCrawlerRequest":true}

Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌5.03%

精彩评论

Sensei Biotherapeutics, Inc.盘中异动早盘股价大跌5.03%